National brain tumour research funding needs to increase to £30-35 million a year
Weekly Neuroscience News From Around the World
Here is a roundup of some of the latest research news stories from around the world that are of interest to the brain tumour community.
Immunotherapy is on everyone’s lips and this article looks at a new drug that may be able to rally the immune system to attack cancer cells in patients with glioblastoma multiforme (GBM) brain tumours.
Also concerning GBM is this piece on the tumour’s “shape-shifting nature” and as Mariella Filbin, MD, PhD says in this article. "It's a very vicious tumour that we haven't gotten a handle on." Brain Tumour Research funds research into GBM at our QMUL research centre.
Another area we fund research into is the ketogenic diet and you may find this piece from Medical News Today of interest.
We want to improve patient options and because of the time and cost of getting new drugs to market the repurposing of existing drugs is something we campaign on. Read about a drug Sanofi developed for MS, which may be effective in treating brain tumour patients.
Broader neuroscience updates out this week include news that mobile phone technology could be used to tackle Alzheimer’s disease plus, research suggests depression treatments should include exercise and a tissue model reveals the role of the blood-brain barrier in Alzheimer’s disease.
There will be further worldwide research news updates in the weeks to com, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.